Cancer Immunotherapy Winter School

sign up below to get an update when applications open for Winter School 2025, from FEBRUARY 11-14, 2025 IN AUSTIN, TX AND VIRTUALLY.

Registration & Venue Details

Registration Details Coming Soon

The Cancer Immunotherapy Winter School is tailored to early career scientists and clinicians that are new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experiences by selecting the educational path most relevant to their learning goals. 

With separate tracks, including clinical and research, participants can tailor their experience by selecting the educational path most relevant to their learning goals.

Travel Awards Available

Applications Opening Soon  |  Eligibility & Criteria  |  2024 Winners

To support young investigators and clinicians interested in attending the Cancer Immunotherapy Winter School, SITC will be offering applications for travel awards. The Cancer Immunotherapy Winter School Travel Awards are intended for individuals who will attend the program in person. Award amounts and eligible expenses are being finalized.

Two of the five travel awards are reserved for individuals from underrepresented racial and ethnic groups in the biomedical sciences field according to the NIH definition. The information collected in response to the self-identifying process will only be viewed by SITC staff and Cancer Immunotherapy Winter School program organizers.

SITC established the Forward Fund in 2012, to stimulate the development and application of cancer immunology and immunotherapy by financially supporting its education and research. Contributions to the Forward Fund help provide grants to promising young post-doctoral researchers, advocate for more young scientists to enter the field of cancer immunotherapy research and much more.

Learn more about the SITC Forward Fund >

Program Organizers

Kristin Anderson, PhD


Kristin Anderson, PhD
University of Virginia

Chrystal Paulos, PhD Winship Cancer Institute


Chrystal Paulos, PhD
Winship Cancer Institute at Emory University

Daniel Powell, PhD


Daniel Powell Jr., PhD
University of Pennsylvania

Christian Capitini, MD

Program Advisor

Christian Capitini, MD
University of Wisconsin-Madison

Program Faculty

Tullia Bruno, PhD
University of Pittsburgh

Peter Bruno, PhD
University of California San Francisco

Deborah Collyar, BS
Patient Advocates in Research

Tricia  Cottrell, MD, PhD
Queen's University

May Daher, MD
The University of Texas MD Anderson Cancer Center

Greg Delgoffe, PhD
University of Pittsburgh

Victor Engelhard, PhD
University of Virgina School of Medicine

Olivera Finn, PhD
University of Pittsburgh

Maryland Franklin, PhD

Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology

Sacha Gnjatic, PhD
Ichan School of Medicine at Mount Sinai

Paloa Grandi, PhD
CG Oncology

Bambi Grilley, RPh
Baylor College of Medicine

Dinesh Kumar, PhD

Lewis Lanier, PhD
University of California San Francisco

Bruce Levine, PhD
Abramson Cancer Center

Michael Lotze, MD, FACS
University of Pittsburgh

Yves Morillon, PhD
U.S. Food and Drug Administration

Yana Najjar, MD
University of Pittsburgh

Robert  Scharpf, PhD
Johns Hopkins University

Sumit Subudhi, MD, PhD
The University of Texas MD Anderson Cancer Center

Ryan  Sullivan, MD
Harvard Medical School, Massachusetts General Hospital

Masataka Suzuki, PhD
Baylor College of Medicine

Christopher Takimoto, MD, PhD
IGM Biosciences

Ned Waller, MD, PhD
Emory University

Jianda Yuan, MD, PhD

Program Details

Continuing Education Credits

Continuing Education Credits will be available for the CIWS 2025 program.

Networking Opportunities

Attendees will have opportunities to expand their professional network, developing new relationships with faculty and other thought leaders through small group breakout sessions and virtual networking features.

Target Audience

  • Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
  • Individuals new to the field working in academic, clinical, industry and government settings

Learning Objectives

Upon completion of the Cancer Immunotherapy Winter School, participants are able to:

  • Describe the core principles of tumor immunology and cancer immunotherapy
  • Discuss recent advancements in drug and biomarker technologies and their clinical application
  • Explain appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design

Program Statement on Diversity, Equity and Inclusion

The Society for Immunotherapy of Cancer (SITC) understands the value of diversity, equity and inclusion and is committed to closing gaps within all facets of the organization, as well as ones in the field of immuno-oncology and biomedical sciences. Since 2018, SITC has been proactively following the NIH Statement on Diversity for those in underrepresented Populations in the U.S. Biomedical Sciences across planning, solicitation and implementation of all programming, including SITC’s Cancer Immunotherapy Winter School. In 2021, SITC formed the Diversity, Equity  and Inclusion Task Force to ensure participation from nationally underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged backgrounds and women from biomedical sciences throughout all society programs and initiatives.

Enduring Materials

Enduring materials are available as permitted by presenters from this past year's 2023 Cancer Immunotherapy Winter School.

Program registrants receive complimentary access to on-demand content.

Enduring materials are available for purchase for those who did not register to attend the program. A discount is available for SITC Members. Renew your dues or become a SITC member today.

View or Purchase CIWS 2023 Enduring Materials >

Related Resources

SITC offers a variety of resources about tumor immunology and cancer immunotherapy. Explore the pages below to learn more.

Basic Cancer Immunotherapy Principles

Learn the fundamentals of cancer immunotherapy through a variety of SITC programs.

Explore Resources


Discover how SITC is leveraging bioinformatics to enhance cancer immunotherapy research and treatments.

Learn More


SITC’s clinician resources includes programs on biomarkers in the field of immuno-oncology.

Read More

Clinical Data and Practical Considerations

Explore SITC's journal, the Journal for Immunotherapy of Cancer (JITC), and other clinical resources.

View More

Combination Therapies

Discover related SITC resources about Combination Therapies.

Explore Programs

Practical Application Resources

Explore SITC's resources to learn about disease specific treatment algorithms, identification and treatment of common irAEs and how to overcome challenges in the clinic.

Learn More

Professional Development

Discover related SITC resources about Professional Development.

Browse Programs